In the last four years, 200 VC investors have backed U.S.-based companies in the Biotechnology industry, according to the PitchBook Platform. Following a healthy year in 2009 with over $800 million invested, VC financings dipped down to $330 million in 2010. 2011 and 2012 have demonstrated an upward trend with investments of $697 million and $702 million, respectively.* Of the 200 investors behind these financings, 27 manage between $500 million and $1 billion in assets, while another 41 manage between $1 billion and $5 billion. To see the full list, contact us here.